Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
353 studies found for:    H1n1 | "Influenza, Human"
Show Display Options
Rank Status Study
1 Completed
Has Results
CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations
Condition: Influenza
Intervention: Biological: Inactivated H1N1 Vaccine
2 Completed
Has Results
Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations
Condition: Influenza
Intervention: Biological: Inactivated H1N1 Vaccine
3 Completed
Has Results
Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels
Condition: Influenza
Intervention: Biological: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A
4 Withdrawn CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
Condition: Influenza
Interventions: Biological: AS03;   Biological: Inactivated H1N1 Vaccine
5 Completed
Has Results
Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
Condition: Influenza
Interventions: Drug: AS03;   Biological: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A
6 Completed Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In Lebanon
Conditions: A/H1N1 Influenza;   Swine Flu
Intervention:
7 Completed Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population
Condition: Influenza
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine, inactivated
8 Completed
Has Results
Safety and Efficacy of an H1N1 Influenza Vaccine in People With Asthma
Condition: H1N1 Influenza Virus
Interventions: Biological: H1N1 vaccine high dose;   Biological: H1N1 vaccine low dose
9 Completed Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders
Condition: Influenza
Intervention: Biological: Influenza A (H1N1) 2009 monovalent vaccine, inactivated
10 Completed A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Intervention: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated)
11 Completed Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
Conditions: H1N1 Influenza;   Seasonal Influenza
Intervention:
12 Completed A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + adjuvant)
13 Completed A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)
14 Completed A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines
Condition: Influenza
Intervention: Biological: H1N1 influenza A Vaccine (Split virion), Inactivated
15 Completed A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Intervention: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated)
16 Completed Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine
Conditions: Novel Influenza A (H1N1);   A New Flu Virus of Swine Origin
Intervention: Other: Non-intervention observational study
17 Completed Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants
Condition: Influenza
Interventions: Biological: Pandemic influenza A/H1N1 vaccine;   Biological: Seasonal trivalent vaccine
18 Completed Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination Device
Condition: Influenza Infection
Intervention: Biological: S-OIV H1N1 vaccine
19 Completed Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age
Condition: Pandemic Influenza
Intervention: Biological: Monovalent A/H1N1 influenza vaccine
20 Completed Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine
Condition: Seasonal Influenza
Interventions: Biological: Placebo;   Biological: A/H1N1 2009 Influenza VLP Vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.